Società Prodotti Antibiotici completed the acquisition of a 40% stake in IDI Farmaceutici from Fondazione Luigi Maria Monti.

Società Prodotti Antibiotici, an Italian pharmaceutical company, completed the acquisition of a 40% stake in IDI Farmaceutici, an Italian biotech and pharmaceutical company specializing in dermatology and dermatological products, from Fondazione Luigi Maria Monti, a nonprofit organization. Financial terms were not disclosed.